In the field of Traditional and Complementary Medicine, it is important for our physicians operating in the field of Traditional and Complementary Medicine to make available safe, dosed and health-standardized products that they can prescribe. For this purpose, "Ruscus Aculeatus L. Plant Root Extract", the first product produced in the Traditional Herbal Medicinal Product Development Project, is indicated for Venous Circulation Disorders (vasoconstrictor).

The licensing of the product within the scope of the Traditional Herbal Medicinal Product Regulation has reached the final stage. The commercialization of the product will be realized through a project/licensing protocol agreement between ATABAY Kimya Sanayi and MAM. With the agreement, it is planned that the license application will be made in September 2020 and commercial production will be realized in January 2021.

With another protocol signed with the same company, it is envisaged that the studies of 5 new products other than Ruscus Aculeatus L. Plant Root Extract can be carried out.